“…In this publication and in our series, patients with 11-hydroxylase seem to be overrepresented, considering the low proportion of 11-hydroxylase-deficient patients among all children with CAH. While there are several case reports about single issues (Bentinck et al , 1956;Prader, 1958;Wiedemann, 1965;Weldon et al , 1966;Gillenwater et al , 1970;Stolecke, 1970;Hoepffner & Sandig, 1971;Wyatt et al , 1987; Hoepffner et al , 1988), very little has been published about growth, final height and the long-term outcome of these rare patients. In the following, we will discuss these problems systematically.…”